Terms: = Prostate cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Prognosis
19 results:
1. Exportin 1 inhibition prevents neuroendocrine transformation through sox2 down-regulation in lung and prostate cancers.
Quintanal-Villalonga A; Durani V; Sabet A; Redin E; Kawasaki K; Shafer M; Karthaus WR; Zaidi S; Zhan YA; Manoj P; Sridhar H; Shah NS; Chow A; Bhanot UK; Linkov I; Asher M; Yu HA; Qiu J; de Stanchina E; Patel RA; Morrissey C; Haffner MC; Koche RP; Sawyers CL; Rudin CM
Sci Transl Med; 2023 Aug; 15(707):eadf7006. PubMed ID: 37531417
[TBL] [Abstract] [Full Text] [Related]
2. ASCL1-mediated ferroptosis resistance enhances the progress of castration-resistant prostate cancer to neurosecretory prostate cancer.
Nie J; Zhang P; Liang C; Yu Y; Wang X
Free Radic Biol Med; 2023 Aug; 205():318-331. PubMed ID: 37355053
[TBL] [Abstract] [Full Text] [Related]
3. Total flavonoids of Litchi seed attenuate stem cell-like properties in breast cancer by regulating Notch3 signaling pathway.
Liao Y; Luo Z; Liu Y; Xue W; He S; Chen X; Ren H; Yang X; Zhu D; Su Z; Huang Q; Guo H
J Ethnopharmacol; 2023 Apr; 305():116133. PubMed ID: 36603788
[TBL] [Abstract] [Full Text] [Related]
4. TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer.
Fan L; Gong Y; He Y; Gao WQ; Dong X; Dong B; Zhu HH; Xue W
Oncogene; 2023 Feb; 42(8):559-571. PubMed ID: 36544044
[TBL] [Abstract] [Full Text] [Related]
5. Immune Biomarkers in Metastatic Castration-resistant prostate cancer.
Fenor de la Maza MD; Chandran K; Rekowski J; Shui IM; Gurel B; Cross E; Carreira S; Yuan W; Westaby D; Miranda S; Ferreira A; Seed G; Crespo M; Figueiredo I; Bertan C; Gil V; Riisnaes R; Sharp A; Rodrigues DN; Rescigno P; Tunariu N; Liu XQ; Cristescu R; Schloss C; Yap C; de Bono JS
Eur Urol Oncol; 2022 Dec; 5(6):659-667. PubMed ID: 35491356
[TBL] [Abstract] [Full Text] [Related]
6. TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of sox2 by SLUG and TWIST1.
Lee Y; Yoon J; Ko D; Yu M; Lee S; Kim S
J Exp Clin Cancer Res; 2021 Nov; 40(1):372. PubMed ID: 34809669
[TBL] [Abstract] [Full Text] [Related]
7. THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple-Negative Breast cancer.
Bai X; Ni J; Beretov J; Wang S; Dong X; Graham P; Li Y
Adv Sci (Weinh); 2021 Dec; 8(24):e2102658. PubMed ID: 34708581
[TBL] [Abstract] [Full Text] [Related]
8. Knockdown of ZEB1 reverses cancer stem cell properties in prostate cancer cells.
Pérez G; López-Moncada F; Indo S; Torres MJ; Castellón EA; Contreras HR
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760173
[TBL] [Abstract] [Full Text] [Related]
9. Clinical and Biological Features of Neuroendocrine prostate cancer.
Yamada Y; Beltran H
Curr Oncol Rep; 2021 Jan; 23(2):15. PubMed ID: 33433737
[TBL] [Abstract] [Full Text] [Related]
10. The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells.
Andreucci E; Peppicelli S; Ruzzolini J; Bianchini F; Biagioni A; Papucci L; Magnelli L; Mazzanti B; Stecca B; Calorini L
J Mol Med (Berl); 2020 Oct; 98(10):1431-1446. PubMed ID: 32803272
[TBL] [Abstract] [Full Text] [Related]
11. The role of SOX family members in solid tumours and metastasis.
Grimm D; Bauer J; Wise P; Krüger M; Simonsen U; Wehland M; Infanger M; Corydon TJ
Semin Cancer Biol; 2020 Dec; 67(Pt 1):122-153. PubMed ID: 30914279
[TBL] [Abstract] [Full Text] [Related]
12. Clinical and molecular features of treatment-related neuroendocrine prostate cancer.
Akamatsu S; Inoue T; Ogawa O; Gleave ME
Int J Urol; 2018 Apr; 25(4):345-351. PubMed ID: 29396873
[TBL] [Abstract] [Full Text] [Related]
13. A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells.
Zhang Y; Huang Y; Jin Z; Li X; Li B; Xu P; Huang P; Liu C
Tumour Biol; 2016 Sep; 37(9):11973-11981. PubMed ID: 27113741
[TBL] [Abstract] [Full Text] [Related]
14. SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in prostate cancer Cells.
Handle F; Erb HH; Luef B; Hoefer J; Dietrich D; Parson W; Kristiansen G; Santer FR; Culig Z
Mol Cancer Res; 2016 Jun; 14(6):574-85. PubMed ID: 27053681
[TBL] [Abstract] [Full Text] [Related]
15. N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells.
Wang M; Ren D; Guo W; Huang S; Wang Z; Li Q; Du H; Song L; Peng X
Int J Oncol; 2016 Feb; 48(2):595-606. PubMed ID: 26647992
[TBL] [Abstract] [Full Text] [Related]
16. The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers.
Ong CW; Chong PY; McArt DG; Chan JY; Tan HT; Kumar AP; Chung MC; Clément MV; Soong R; Van Schaeybroeck S; Waugh DJ; Johnston PG; Dunne PD; Salto-Tellez M
Oncotarget; 2015 May; 6(14):12763-73. PubMed ID: 25906747
[TBL] [Abstract] [Full Text] [Related]
17. A three-gene signature and clinical outcome in esophageal squamous cell carcinoma.
Sun LL; Wu JY; Wu ZY; Shen JH; Xu XE; Chen B; Wang SH; Li EM; Xu LY
Int J Cancer; 2015 Mar; 136(6):E569-77. PubMed ID: 25220908
[TBL] [Abstract] [Full Text] [Related]
18. Regulators of prostate cancer stem cells.
Kerr CL; Hussain A
Curr Opin Oncol; 2014 May; 26(3):328-33. PubMed ID: 24651383
[TBL] [Abstract] [Full Text] [Related]
19. Elevating sox2 levels deleteriously affects the growth of medulloblastoma and glioblastoma cells.
Cox JL; Wilder PJ; Desler M; Rizzino A
PLoS One; 2012; 7(8):e44087. PubMed ID: 22937156
[TBL] [Abstract] [Full Text] [Related]